OSIS

Analyst Note: OSI Systems, Inc. (OSIS)

Date: June 13, 2026 Current Price: $222.78

1. Structural Readiness

Current Price: $222.78 Extension: Not applicable (price is currently in the consolidation phase, not extended from a breakout)

2. Thesis Layer

Primary Secular Thesis: Defense Modernization (C4ISR / Sensors / EW) Exposure: Tier Second-Order | Confidence: Moderate

OSIS is a direct beneficiary of the global shift toward advanced C4ISR (Command, Control, Communications, Computers, Intelligence, Surveillance, and Reconnaissance) and electronic warfare capabilities. The company's role is defined by its vertically integrated model, which allows it to provide both the hardware (sensors, radar subsystems) and the manufacturing flexibility required for modern defense supply chains.

Additional Secular Tailwinds:

• Supply Chain Diversification: A structural move away from China, with OSIS leveraging its global footprint (US, Europe, Asia) to serve customers seeking supply chain resilience.
• Healthcare Infrastructure Growth: Aging demographics in developed markets and infrastructure build-out in emerging markets driving demand for patient monitoring and diagnostic systems.
• Regulatory Mandates: International mandates (e.g., EU CCEI, 100% cargo scanning) driving demand for advanced inspection technologies.

The combination of these themes creates a multi-wave exposure. The Defense Modernization thesis provides the immediate revenue catalyst (backlog growth), while the supply chain shift and healthcare demographics provide a longer-duration structural floor for the business model.

3. Business Overview

Business Model: OSI Systems operates as a vertically integrated designer and manufacturer of advanced electronic systems and components across three distinct segments: Security, Healthcare, and Optoelectronics and Manufacturing.

Key Business Metrics & Evidence (as of May 4, 2026):

• Backlog Strength: The company ended the quarter with a backlog of approximately $1.9 billion, the highest in the company's history. This provides significant revenue visibility.
• Remaining Performance Obligations (RPO): As of March 31, 2026, the transaction price allocated to remaining performance obligations was $877.2 million. Management expects to recognize revenue on approximately 37% of these obligations over the next 12 months, with the remainder recognized thereafter.
• Recent Awards:
• Homeland Defense: A sizable award for an undefinitized contract action (UCA) with a not-to-exceed value of $235 million for over-the-horizon radar transmit subsystems.
• Medical OEM: A $40 million award for electronic subassemblies from a medical OEM, noted as significant given the typical order size in that division is under $5 million.
• Geographic & Customer Mix:
• Security Division: Direct sales to the U.S. Government were approximately $182.8 million for the fiscal year ended June 30, 2025.
• Customer Base: Includes the U.S. Department of Homeland Security, Department of Defense, and international border control authorities.
• Operational Guidance: Management is maintaining fiscal 2026 guidance for revenues and non-GAAP EPS. They expect a reduced revenue impact from Mexico in Q4 compared to Q3, with the headwind largely rolling off as the company enters fiscal 2027.

4. Archetype and Conviction

Archetype: Quality Compounder Fit: The company fits the "Quality Compounder" archetype due to its consistent ability to grow backlog to record highs, maintain disciplined guidance, and execute accretive acquisitions (e.g., the September 2024 acquisition of a critical military/space solutions provider for ~$76 million).

Valuation & Financial Context:

• Forward Consensus: The financial spine indicates a forward consensus EPS of $10.42 for FY1 and $11.44 for FY2.
• Capital Structure: The company has strengthened its balance sheet, extending its credit facility to July 2030 with a revolving limit of $725 million and issuing $575 million in 0.50% convertible senior notes due in 2031.
• Conviction Stack:
• Thesis Strength: High. The defense backlog is at an all-time high, and the "China-plus-one" supply chain narrative is a persistent tailwind.
• Evidence Quality: Strong. Multiple primary sources (earnings transcripts, SEC filings) confirm record backlogs, specific large awards, and clear RPO visibility.
• Structural Quality: High. The vertically integrated model and global manufacturing footprint are cited by management as key differentiators.
• Rerating Potential: Moderate to High. The combination of record backlogs, supply chain diversification, and a "Quality Compounder" profile suggests potential for multiple expansion if the breakout confirms.

Volatility Context:

• Current ATR: 4.8% (High). This falls within the historical "sweet spot" (4–6%) for structural quality setups, indicating sufficient volatility to support a move but not so extreme as to suggest a "severe loser" profile.
• ATR at Breakout: Not yet recorded (awaiting breakout).

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Backlog Growth: Continued expansion of the backlog beyond the $1.9 billion record, particularly in the Security or Optoelectronics segments.
• Margin Expansion: Confirmation that the "reduced revenue impact from Mexico" leads to margin improvement in Q4 and Fiscal 2027.

What Would Invalidate the Case:

• Guidance Reduction: Any reduction in fiscal 2026 guidance or a significant delay in the rollout of the $235 million Homeland Defense award.
• RPO Recognition Issues: If the company fails to recognize the expected 37% of RPO within the next 12 months, it would signal execution risk or demand softening.

Gaps in Evidence:

• Detailed Segment Margins: While total EPS guidance is provided, specific margin breakdowns by segment (Security vs. Healthcare vs. Optoelectronics) for the current quarter are not detailed in the provided evidence.
• Integration Progress: The specific financial impact of the September 2024 acquisition on the current quarter's results is not quantified beyond the acquisition cost.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Record $1.9 billion backlog; $235 million Homeland Defense radar award; 37% RPO recognition expected in next 12 months; maintaining fiscal 2026 guidance. Key risks: Technical setup remains "forming" (no breakout yet); potential execution delays on undefinitized contracts; Mexico revenue headwind timing. Expected path: Management expects Mexico headwinds to roll off in Q4/FY27; backlog conversion to revenue should drive top-line growth; potential for multiple expansion if technical breakout confirms. Expected horizon: 6 to 12 months for thesis to fully play out, contingent on technical breakout.